๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications

โœ Scribed by Anwar, A.J.; Walker, J.D.; Frier, B.M.


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
47 KB
Volume
15
Category
Article
ISSN
0742-3071

No coin nor oath required. For personal study only.

โœฆ Synopsis


Type 1 insulin-dependent, diabetes mellitus (Type 1 DM) is thought to be more prevalent in individuals with Down's syndrome. To ascertain the local prevalence of Type 1 DM in patients with Down's syndrome in a geographically defined area, the four diabetes clinics in Lothian were surveyed and 13 patients with Down's syndrome and Type 1 DM were identified. Using data from previous epidemiological surveys which determined the prevalence of Down's syndrome in the general population, the prevalence rate of Type 1 DM in patients with Down's syndrome was calculated to be between 1.4 and 10.6 %, a prevalence considerably higher than in the general population. Although 7 (54 %) of the Down's syndrome patients were treated with once daily administration of insulin, the mean HbA 1c value of the group was similar to that observed in a control group of 39 age-, sex-and duration-matched Type 1 patients, all of whom were taking two or more injections of insulin daily. Glycaemic control was therefore of similar quality to matched Type 1 patients without Down's syndrome, despite the frequent use of simple insulin regimens, which may relate to the more stable lifestyle of these patients.


๐Ÿ“œ SIMILAR VOLUMES


British Diabetic Association guidelines
โœ Avery, L.; Borsey, D.Q.; Greene, S.A.; Gummerson, I.; Hayes, R.; Kerr, D.; Lean, ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 47 KB ๐Ÿ‘ 1 views

The following article is a report from the Chairman of the Professional Advisory Committee of the British Diabetic Association. The committee, with the help of a number of experts currently working in the field, produced a set of guidelines intended for use by health care professionals on the issues

Relationship between circulating vascula
โœ Koga, M.; Otsuki, M.; Kubo, M.; Hashimoto, J.; Kasayama, S. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 118 KB ๐Ÿ‘ 1 views

The soluble form of the vascular cell adhesion molecule-1 (VCAM-1) is detectable in human sera and is elevated in diabetic patients, with unknown clinical significance. In the present study, the relationship between serum soluble VCAM-1 and diabetic microvascular complications (retinopathy, nephropa

Insulin management and metabolic control
โœ Mortensen, H.B.; Robertson, K.J.; Aanstoot, H.-J.; Danne, T.; Holl, R.W.; Hougaa ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 154 KB

Insulin regimens and metabolic control in children and adolescents with Type 1 diabetes mellitus were evaluated in a cross-sectional, non-population-based investigation, involving 22 paediatric departments, from 18 countries in Europe, Japan, and North America. Blood samples and information were col